Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LDK378 in ROS1/ALK+ Advanced Cholangiocarcinoma
NCT02374489Phase 2Terminated
- Sponsor
- National Health Research Institutes
- Start
- Mar 2015
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ceritinib in intrahepatic cholangiocarcinoma (ICC), hilar cholangiocarcinoma (HC), sponsored by National Health Research Institutes. Started Mar 2015; status: terminated.
02
Drugs
ceritinib
03
Conditions
intrahepatic cholangiocarcinoma (ICC)hilar cholangiocarcinoma (HC)
Beyond the preview
Go deeper on NCT02374489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02374489.